Professional Documents
Culture Documents
Blood Film PDF
Blood Film PDF
The blood film is one of the world’s most widely and frequently used tests
and has undergone remarkably few changes since its introduction as a clinical
diagnostic tool in the late 1800s. The origins of stained blood film microscopy
are somewhat obscure, and a clear reference for the ‘‘first person or persons’’ to
describe its use as a clinical laboratory procedure cannot be established with
certainty. Antonie van Leeuwenhoek, in the seventeenth century, was the first to
describe blood cells, using whole blood preparations and not blood films for his
observations on blood corpuscles. In fact, he would not have been able to use
blood film–based microscopy because it requires considerably more sophisti-
cated optics than were available in his day. A second technologic innovation
enabling blood film microscopy was the introduction of aniline dyes in the
second half of the nineteenth century. This made it possible to study individual
blood cells by light microscopy after a small amount of blood had been placed
and smeared onto glass slides, dried, fixed, and then stained. Paul Ehrlich
introduced eosin as the first of these dyes for staining blood films in 1856,
followed by hematoxylin in 1865, and later by the metachromatic Romanowsky
dyes. A few refinements have since been made, consisting mainly of improve-
ments in dye quality, staining procedures, automation of slide preparation, and
staining, but the basic elements of blood film preparation and analysis have not
changed for over a century.
This article gives direction and some standardization in the preparation of
blood films used for morphologic evaluation in the clinical laboratory. Micro-
scopic analysis procedures and interpretation are not within the scope of this ar-
ticle.
Methodologies that can be labeled as being state of the art and methods
applicable for laboratories in developing countries are quoted. When targets are
stated these are at minimum level, and should be attained under all conditions,
lest diagnostic test quality and patient care be compromised. This is especially
important because results obtained from microscopic analysis of blood films are
often used as final and definitive in clinical situations, whether for screening,
case finding, diagnosis, or monitoring of disease.
Microscope Slides
Cleaning of Slides
the part nearer to the start of the push is too thick for microscopy. Automated
devices are capable of providing excellent-quality blood films, usually with
greater consistency than those obtained by manual methods.18
A serious concern with wedge preparations is the uneven distribution of
different cell types.22 Monocytes (and other large leukocytes) are pushed to the
end of the spreaded film (the feathered edge) and to the sides. This leads to a 5%
to 10% underestimation of monocyte presence when compared with monoclonal
antibody-based flow cytometry differential counts (upper normal limit in pro-
portional count is 11% in normal individuals, not 10% as measured by micros-
copy).13
Anticoagulation
K2 or K3EDTA, sodium citrate, and acid citrate dextrose are all acceptable
but heparin is not because of frequently developing platelet clumps that interfere
with the morphologic interpretation of platelets and of platelet count estimates.
Heparin also causes the development of a purple-blue hue on stained films.
4 HOUWEN
Enough blood should be used to allow for a wedge blood film of appro-
priate thickness and of 2.5 to 4-cm length. If a spinner is operated, a micropipette
should be used for blood delivery on the slide to ensure consistent monolayers.
Typically, for spun slides, 30 L (about one drop) results in a monolayer of
sufficient size, but different volumes may be required for different spinners.
The blood drop should be placed approximately 1 cm from the end of the
slide (opposite labeling end). Alternatively, 1 cm distance from the label (or
frosted part of the slide) can be chosen (this does not apply if the slide label is
placed on the back of the slide). For spinners, handle according to the manufac-
turers’ instructions.
Spreader Slide
Ideally, the spreader slide should be slightly narrower than the glass slide
to minimize distribution effects. In practice, a second slide is often used as a
spreader, and this is acceptable if the spreader slide has rounded or beveled
edges making the spreading width of the slide narrower than the actual slide
width. The edge of a spreader should always be smooth to ensure even thickness
for the entire width of the blood film. Spreaders should be discarded after use,
or cleaned thoroughly and dried before reuse. The presence of blood cells from
a previous specimen on the spreader edge can cause significant carryover of
blood cells, including malaria parasites in red blood cells and leukemic white
blood cells, into the next blood film.
BLOOD FILM PREPARATION AND STAINING PROCEDURES 5
As soon as a blood drop has been placed on the slide, move the spreader
slide slowly backward at approximately a 30- to 45-degree angle toward the
blood drop. The drop should spread quickly along the spreader’s edge. Once
the blood is spread along the entire edge, the spreader should be moved
immediately forward at a steady rate (a fairly fast speed) and held at a 45-
degree angle until all blood has been spread into a film. The spreader should be
held more upright for samples from anemic patients, creating a thicker film and
at a flatter angle for samples with high red blood cell counts. It is notoriously
difficult to produce acceptable wedge blood films from certain specimens, such
as those from newborns.
The faster the blood is spread on the slide the thicker the film. Training and
experience are required for consistent and acceptable results. For slide spinners
centrifugation speeds and times should be available from the manufacturer.
The thickness of the blood film is influenced by the size of the blood drop;
the patient’s red cell count; the angle of the spreader (the greater the angle the
thicker and shorter the blood film); and the speed of spreading (fast spreading
creates thicker blood films).
Coverglass
Mounting Media
Labeling Requirements
Long-Term Storage
If blood films are stored for long periods, exposure to light should be
avoided. Although coverslipping is recommended for long-term storage, deterio-
ration of the films is unlikely to occur if stained slides without coverslips are
kept closely packed, in a dark, dry environment in closed containers or cabinets.
also much more expensive. For some time to come, the morphologic identifica-
tion of malaria will remain in many laboratories as a major method for detection
and monitoring of malaria. For morphologic detection of malaria parasites both
regular and thick blood film preparations should be used. Identification of
malaria is 10 times more sensitive in thick preparations than in regular blood
films, but the actual identification of the type of malaria parasites is less easy in
thick preparations. For thick film preparations a small drop of blood is placed
on a glass slide and spread to approximately four times its original surface.
After extensive drying, best done at 50 to 60C for 7 to 10 minutes, the slides
can be stained. The cells wash off the slide if insufficiently dried. Two staining
procedures have been described: (1) two rapid procedures taking less than 30
seconds for regular blood films and (2) a Giemsa-based procedure for thick
drop preparations, taking about 30 minutes. As an alternative for thick drop
preparations a method has been described that uses blood cell lysis by saponin
followed by a centrifugation step to remove debris.
Reticulocyte Preparation
Preparation Artifacts
The most common artifacts are caused by poor spreading techniques, slow
drying in humid conditions, insufficient or delayed fixation, and fixing solutions
that contain water. Slides that are not completely dry result in poorly or irregu-
larly spread blood films, often with poor morphology as a result. Certain cell
types can be damaged easily by the blood film preparation itself. Specific
conditions include those with large numbers of atypical lymphocytes, chronic
lymphocytic leukemia, and acute leukemia. Sometimes these ruptured cells
(smudge cells or Gumprechtse Schollen) can be prevented from occurring by the
addition of albumin to the blood sample before blood film preparation.
Slow drying causes cells to contract, whereas water in excess of 3% in the
methanol fixing solution can cause gross morphologic artifacts, such as decreas-
ing crispness of cellular (especially red blood cell and nuclear) appearance and
the development of artificial vacuoles. Degenerative changes, such as cyto-
plasmic vacuolization in monocytes and neutrophils, nuclear lobulation, or frag-
8 HOUWEN
mentation of nucleated cells, and apoptotic changes are not so much the result
of preparation but are often caused by prolonged or inadequate sample storage.
See the article on artifacts in peripheral blood elsewhere in this issue for a
discussion of common artifacts and illustrations.
Possible Interferences
Patient conditions influencing and interfering with the preparation and the
quality of blood films include anemia, polycythemia, blood specimens from
newborns, cord blood, platelet clumping, cold agglutinins, anti–red blood cell
antibodies in severe hemolytic anemia, severe rouleaux formation, and chronic
lymphocytic leukemia.
Reagent Safety
Disposal of Slides
Blood films can be used in a number of ways. Most are used for routine,
clinical quantitative or qualitative analysis of formed blood elements. Its use-
fulness for morphologic screening is probably stronger than for purely quantita-
tive purposes now that electronic white blood cell differential analysis has been
much improved. Estimation of cell counts, such as platelets from a blood film,
is highly subjective and shows poor correlation with analyzer results or reference
counts (Houwen B, unpublished observations).
Blood films are also used for quality control and quality assurance purposes
and for evaluation of automated, instrument-based methods.12, 15
Care should be taken that blood films are properly fixed and stained and
that slides are adequately labeled. A good quality blood film preparation should
contain a sufficiently large area for morphologic evaluation. Typically, areas for
morphologic assessment should be large enough that at least 100 WBC can be
identified in samples with a WBC count within the reference interval for that
specific individual. In a wedge blood film preparation the best area for micros-
copy is where red blood cells barely touch each other. Spun films typically have
large monolayer areas. Cells should not be damaged by the preparation or
staining procedure, or by excessive shear forces. Especially in spun films, care
must be taken that none of the cell types in the monolayer are distorted by the
preparative procedure. In certain disease conditions, however, such as chronic
lymphocytic leukemia, it is difficult to prevent cellular damage to the affected
cells. For repeated microscopic analysis it is recommended to use a coverslip, so
that removal of immersion oil does not damage the blood films for future analy-
sis.
Microscopy
Methods for proper microscopic analysis of blood films have been described
elsewhere and are outside the scope of this article.
Quality Control
Proficiency Testing
Optimal results are obtained by fixing and staining directly after the blood
film is completely air-dried. Fixation of blood films before staining is recom-
mended, although many laboratories have a practice of staining immediately
after air-drying of blood films. This usually yields acceptable results. If slides
cannot be stained immediately, however, fixation in methanol is necessary within
4 hours, but preferably less than or equal to 1 hour, after air-drying; otherwise,
the plasma causes gray-blue background effects. Staining and fixing solutions
must be free from water as much as possible (⬍3%) to prevent morphologic
artifacts. If manual staining procedures are used it is generally recommended
that slides be immersed in reagent-filled (Coplin) jars rather than by covering
slides with staining solution because this may lead to the formation of precipitate
by evaporation. If staining is performed under extremely hot conditions, care
must be taken to prevent evaporation during staining, for instance by per-
forming staining in a closed jar or in a closed petri dish.
Automated staining devices have their own specific staining procedures as
provided by the device manufacturers. Users may modify these procedures to
satisfy local requirements in terms of cell staining. Staining protocols vary
between laboratories and no generally accepted routine staining method or
result is available. Guidelines for staining and staining results can be found in
hematology and laboratory guidelines and textbooks. The International Council
for Standardization in Haematology has published a reference staining method
for blood films, based on purified azure B and eosin Y solutions.21
As a general rule for judging the quality of a stained blood film the
laboratory must ensure that all cell types in a blood film can be identified
reliably by the staining procedure followed. This applies equally to manual and
automated methods. Blood films are typically stained by Romanowsky dyes
(consisting of a variety of thiazines and eosins). A number of methods have
been described and include Wright, Wright-Giemsa, May-Grünwald-Giemsa,
and Leishman. Examples of commonly used methods for staining of air-dried
blood films are given later.
Stains and fixing materials must be kept in tightly closed containers at room
temperature. Freezing temperatures destroy Romanowsky stains. Blood film
staining reagents should have labels that record when containers were opened;
expiration dates should be on containers when applicable. Although the raw
materials are readily available and the laboratory can make up all stains, it
should be noted that this is a laborious process and that in general more
consistent staining results are obtained when ready-to-use staining solutions are
being applied.
Wright Stain
Reagents. These are absolute methanol and staining solution, which can be
purchased as a ready-made solution or as a powder from commercial sources.
Typically, 0.3 g of Wright stain powder is dissolved in 100 mL of absolute
methanol and left in a closed container at room temperature for 24 hours. It
must be filtered before use. The third reagent is Sörensen’s buffer solution at pH
12 HOUWEN
May-Grünwald-Giemsa Stain
Reagents. These are absolute methanol and staining solution. Staining solu-
tion 1 is 0.3 g May-Grünwald powder in 100 mL absolute methanol, left in a
closed container at room temperature for 24 hours. It must be filtered before
use. Staining solution 2 (Giemsa stain) is 1 g Giemsa stain powder dissolved in
66 mL glycerol, and heated to 56C for 90 to 120 minutes. After the addition of
66 mL of absolute methanol and thorough mixing, the solution is left at room
temperature in a closed container. It must be filtered before use. The buffer is
Sörensen’s buffer solution, but instead of pH 6.4 as in Wright stain the pH must
be at 6.8 for the May-Grünwald-Giemsa stain.
Procedure. The procedure consists of the following steps:
Step 1. Fixate for at least 30 seconds in absolute methanol
Step 2. Remove the methanol by tilting the slide or by simply removing it
from the fixing jar
Step 3. Apply staining solution 1 freshly diluted with an equal part of buffer
for 5 minutes on a horizontally positioned slide or in a jar
Step 4. Transfer the slide from the jar without washing (or remove staining
solution by holding slide vertically) into staining solution 2 that has
been freshly diluted with nine parts of buffer for 10 to 15 minutes
Step 5. Transfer the slide to the jar with buffer for one rinse, after remov-
ing stain
Step 6. Wash the slide with ample water
Step 7. Transfer the slide to a jar containing water for 2 to 5 minutes
Step 8. Dry the slide in a tilted position; do not blot dry
Step 9. Mount with a coverglass if desired
It is essential in this method that slides not be allowed to dry or evaporate
between steps, otherwise staining artifacts and precipitate form.
Reticulocyte Stain
complete inversions at least two blood films are prepared on glass slides and air
dried before microscopic analysis.
Malaria Stains
Field Stain
Reagents. For stain 1, 1.3-g eosin Y is dissolved by active stirring in 500-mL
distilled water containing Na2HPO4.12H2O 12.6 g and KH2PO4 6.25 g. This
should stand at room temperature for 24 hours in a closed container. For stain
2, 1.3 g methylene blue is dissolved in 500 mL distilled water containing
Na2HPO4.12H2O 12.6 g and boiled to dry powder to polychrome the dye. The
powder is resuspended in 500 mL distilled water and KH2PO4 6.25 g is added.
Alternatively, staining solution 1 may be made by dissolving 0.8 g methyl-
ene blue and 0.5 g methylene azure (azure 1, an oxidated derivative of methylene
blue) in 500 mL distilled water containing Na2HPO4.12H2O 12.6 g and KH2PO4
6.25 g. No evaporation step is necessary. Both staining solutions must be filtered
before use and kept in a closed container to prevent oxidation.
Procedure. Dried but otherwise unfixed thin films and thick drop prepara-
tions can be dipped into stain 1 for 1 to 2 seconds, followed by a rinse in
Sörensen’s buffer pH 6.8 until no more stain is released from the blood film.
Next, the film is dipped for 1 second in stain 2, and rinsed immediately in the
same buffer. The slide is dried in vertical position after excess water has been
removed by shaking, not blotting.8
Alternate Staining Procedure for Malaria Examination on Regular Blood
Films.
Step 1. Fix slides for at least 30 seconds in absolute methanol
Step 2. 12 drops of diluted stain 1 are placed on a blood film (one part stain
diluted by four parts distilled water)
Step 3. Add immediately 12 drops of undiluted stain 2 and mix with the
diluted stain 1 already on the slide
Step 4. Let stand for 1 minute
Step 5. Drain slide and place in Sörensen’s phosphate buffer pH 6.6 for
5 seconds (for full development of staining)
Step 6. Wash with water
Step 7. Dry by tilting the slide; do not blot dry
References
1. Bacus JW: Erythrocyte morphology and ‘‘spinner’’ blood film preparations. J Histo-
chem Cytochem 22:506–516, 1974
2. Bentley SA: Quality control and the differential leukocyte count. Clin Lab Haematol
12(suppl 1):101–109, 1990
3. Beutler E, Lichtman MA, Coller BS, et al: Williams Hematology, ed 5. New York,
McGraw Hill, 1995
4. Chanarin I: Laboratory Haematology. Edinburgh, Churchill Livingston, 1989
5. Dacie JV, Lewis SM: Practical Haematology, ed 5. Edinburgh, Churchill Livingston, 1975
6. Devices for collection of skin puncture blood specimens. NCCLS Approved Guideline
H14-A2, 1990
7. Evacuated tubes and additives for blood specimen collection. NCCLS Approved Stan-
dard H1-A4, 1996
8. Field JW: The morphology of malarial parasites in thick blood film preparations. Part
IV. The identification of species and phase. Trans R Soc Trop Med Hyg 34:405, 1940
9. Gleeson RM: An improved method for thick film preparation using saponin as a lysing
agent. Clin Lab Haematol 19:249–251, 1997
10. Henry JB: Clinical Diagnosis and Management by Laboratory Methods, ed 18. Philadel-
phia, WB Saunders, 1991
11. Hull BP, Bakhiet N, Ryu J, et al: Biohazard evaluation of laboratory hematology
tests. Presented at the 7th International Symposium on Technological Innovations in
Laboratory Hematology, Lake Tahoe, NV, 1994
12. International Council for Standardization in Haematology (ICSH): ICSH reference
method for staining of blood and bone marrow by azure B and eosin Y (Romanowsky
stain). Br J Haematol 57:707–710, 1984
13. Lebeck LK, Mast BJ, Houwen B: Flow cytometric white blood cell differential: A
proposed alternate reference method. Sysm J Int 3:61–69, 1993
14. Lee RG, Bithell TC, Foerster J, et al: Wintrobe’s Clinical Hematology, ed 9. Philadelphia,
Lea and Febiger, 1993
15. Lewis SM: Blood film evaluations as a quality control activity. Clin Lab Haematol
12(suppl 1):119–127, 1990
16. Megla GK: Automatic blood film preparation by rheologically controlled spinning. Am
J Med Technol 42:336–342, 1976
17. Nourbaksh M, Atwood JG, Raccio J, et al: An evaluation of blood smears made by a
new method using a spinner and diluted blood. Am J Clin Pathol 70:885–892, 1978
18. Pawlick G, Relopez J: Kaiser Permanente interlaboratory abnormal cell study compar-
ing slide quality of the Sysmex SP-100 automated slide maker/stainer to manual
technique. Sysm J Int, in press
19. Procedures for the collection of diagnostic blood specimens by skin puncture. NCCLS
Approved Standard H4-A3, 1991
20. Procedures for the collection of diagnostic blood specimens by venipuncture. NCCLS
Approved Standard H3-A4, 1998
21. Reference leukocyte differential count (proportional) and evaluation of instrumental
methods. NCCLS Approved Standard H20-A, 1992
22. Stiene-Martin EA: Causes for poor leukocyte distribution in manual spreader-slide
blood films. Am J Med Technol 46:624–632, 1980
23. Wenk RE: Comparison of five methods for preparing blood smears. Am J Med Technol
42:71–78, 1976
24. Wolley RC, Dembitzer HM, Herz F, et al: The use of a slide spinner in the analysis of
cell dispersion. J Histochem Cytochem 24:11–15, 1976
e-mail: bhouwen@beckman.com